Medical Condition News

RSS

Gottlieb allergist issues high mold air alert for the Midwest

Chicago's mold count today is 54,000 -well over the 50,000 threshold that signals a dangerous air quality warning. This is the third time a high mold alert has been declared in the 2011 allergy reporting season. "Headaches, sinus congestion, runny noses and fatigue will be common among Chicagoans," says Dr. Joseph Leija, allergist, who performs the official allergy count at Loyola University Health System's Gottlieb Memorial Hospital.

14 Sep 2011

Spices boost broccoli's power to fight cancer

Teaming fresh broccoli with a spicy food that contains the enzyme myrosinase significantly enhances each food's individual cancer-fighting power and ensures that absorption takes place in the upper part of the digestive system where you'll get the maximum health benefit, suggests a new University of Illinois study.

14 Sep 2011

Lexicon's LX4211 clinical data presented at EASD annual meeting

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that the company is presenting clinical data this week at the European Association for the Study of Diabetes (EASD) annual meeting in Lisbon, Portugal.

14 Sep 2011

Children with more ADHD symptoms twice as likely to get hurt

Injury kills more 11-year-olds in the United States than all other causes combined, and a new study from University of Alabama at Birmingham reveals ADHD almost doubles the risk of serious injury among this age group.

14 Sep 2011

Tengion reinitiates enrollment in Neo-Urinary Conduit clinical trial for bladder cancer

Tengion, Inc. today announced that it has reinitiated enrollment of patients in the ongoing initial clinical trial of its lead product candidate, the Neo-Urinary Conduit, which is being evaluated in bladder cancer patients requiring a urinary diversion following bladder removal.

14 Sep 2011

Efficient, economical molecule could speed evaluation of some anti-cancer treatments

Researchers from Boston College have developed a new class of small molecule receptors capable of detecting a lipid molecule that reveals the telltale signs of cellular death, particularly cancer cells targeted by anti-cancer drugs, the team reports in the current electronic edition of the Journal of the American Chemical Society.

14 Sep 2011

VIVUS presents positive results from avanafil phase 3 study in diabetics at 47th EASD meeting

VIVUS, Inc. today presented positive results from the avanafil phase 3 study in diabetics. In the REVIVE-Diabetes study (TA-302), male diabetics receiving avanafil had significant improvement in erectile function.

14 Sep 2011

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

ViroPharma Incorporated and Halozyme Therapeutics announced today that ViroPharma has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme, in subjects with hereditary angioedema.

14 Sep 2011

OBT, Seattle Genetics form strategic collaboration to discover novel ADCs for cancer

Seattle Genetics, Inc. and Oxford BioTherapeutics today announced that they have formed a strategic collaboration to jointly discover novel antibody-drug conjugates (ADCs) for cancer.

14 Sep 2011

Genetic variant associated with increased long-term mortality risk after coronary artery bypass graft procedure

Duke University Medical Center researchers have found a genetic variant that seems to be associated with lower five-year survival after a coronary artery bypass.

14 Sep 2011

Practical NCD guide for everyone to improve their health

The world's health professions have launched an easy-to-use, practical guide to help individuals and their health professionals reduce the risk of noncommunicable diseases (NCDs) - conditions which currently account for 60% of global deaths.

14 Sep 2011

USU, HJF to host 'The TBI Spectrum' symposium on Sept. 22

New Jersey Congressman and former Philadelphia Eagles offensive lineman Jon Runyan and Army Vice Chief of Staff General Peter Chiarelli will deliver keynote addresses at the fourth USU-HJF Military Medicine Symposium, "The TBI Spectrum," Sept. 22, 2011.

14 Sep 2011

Acceleron commences ACE-536 Phase 1 clinical trial in anemia

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.

14 Sep 2011

Henry Ford study identifies 23 microRNAs for laryngeal cancer

A Henry Ford Hospital study has identified 23 microRNAs for laryngeal cancer, a discovery that could yield new insight into what causes certain cells to grow and become cancerous tumors in the voice box.

14 Sep 2011

African-Americans have higher risk of high blood pressure earlier

...

13 Sep 2011

High cholesterol and Alzheimer's disease

New research suggests that high cholesterol levels could boost the risk of Alzheimer's disease by creating more brain-clogging bits known as plaque. Researchers however didn't find any link between high cholesterol and tangles, which also clog the brain in those with Alzheimer's.

13 Sep 2011

A squirt of insulin up the nose for prevention of Alzheimer’s disease

Researchers have noted in a small pilot study that squirting insulin deep into the nose where it travels to the brain might hold early Alzheimer’s disease at bay. At present there are no effective ways to prevent or delay the progress of Alzheimer’s. More than 5.4 million Americans and 35 million people worldwide have Alzheimer's, the most common form of dementia.

13 Sep 2011